Xilio Therapeutics, Inc. (BOATS:XLO) Financings

Xilio Therapeutics, Inc.

Financings

RaiseDate
Public offering of pre-funded warrants
Announced: about US$40M · US$0.5349 a share · Warrants at US$0.0001 · Leerink Partners
Dealers: Leerink Partners (lead)
Buyers: Coastlands Capital (led the financing; existing investor); Gilead Sciences, Inc.; OrbiMed; Perceptive Advisors
Use of proceeds: Advance development of product candidates, working capital and general corporate purposes
Feb 12, 2026
Public offering of pre-funded warrants accompanied by Series A, Series B and Series C warrants
Closed: US$50M raised · US$0.7499 a share · Warrants at US$0.75 · Leerink Partners
Dealers: Leerink Partners (lead)
Buyers: Coastlands Capital; Frazier Life Sciences; Gilead Sciences, Inc.; Logos Capital; Samsara BioCapital
Use of proceeds: Advance development of product candidates, working capital and general corporate purposes
Jun 5, 2025

Read by 6ix AI from the company's releases